NCT02977923 (DREAM-P) is a NA clinical trial of VR distraction via Oculus Rift in Pain, sponsored by St. Justine's Hospital.

Who is sponsoring NCT02977923?

NCT02977923 is sponsored by St. Justine's Hospital.

What drugs are being tested in NCT02977923?

Interventions in NCT02977923: VR distraction via Oculus Rift, Standard pharmacological treatment.

What condition does NCT02977923 study?

NCT02977923 studies Pain, Anxiety, Burns, Child, Injuries.

Is NCT02977923 still recruiting?

NCT02977923 is currently completed. Last updated 21 September 2018.

Last reviewed 2018-09-21 · How we verify

NCT02977923: DREAM-P

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: a Pilot Study

Completed NA Last updated 21 September 2018

What this trial tests

NA trial testing VR distraction via Oculus Rift in Pain in 20 participants. Completed in 1 August 2018.

Timeline

10 July 2017

Primary endpoint
1 August 2018

1 August 2018

Quick facts

Lead sponsor	St. Justine's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	10 July 2017
Primary completion	1 August 2018
Estimated completion	1 August 2018
Sites	1 location across Canada

Drugs / interventions tested

VR distraction via Oculus Rift
Standard pharmacological treatment

Conditions studied

Pain — all drugs for Pain →
Anxiety — all drugs for Anxiety →
Burns — all drugs for Burns →
Child — all drugs for Child →

Sponsor

St. Justine's Hospital

Who can join

Adults 7 to 18, any sex, with Pain or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children with injuries, including burns, experience severe pain intensity during medical procedures despite the increasing doses of analgesics. Current guidelines on pediatric procedural pain management recommend the combination of non-pharmacological and pharmacological interventions to enhance pain management and decrease the numerous side effects of analgesics. Virtual reality (VR) has gained growing consideration as a non-pharmacological method as it engages multiple senses and allows interactions with a virtual world. Oculus Rift ® (OR) is a new technology in VR that provides more immersiveness, at a relatively low cost, and could probably improve the management of pain and anxiety in wound care. Overall hypothesis: Distraction by VR via the OR, in combination with the standard pharmacological treatment, is a feasible, acceptable and satisfactory method for the management of pain and anxiety during wound-related treatments in children with injuries. Note that this pilot study will precede a larger trial aimed at assessing the effect of virtual reality distraction via the Oculus Rift ® (DREAM-T: NCT02947243)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Virtual reality distraction for acute pain in children.
Lambert V, Boylan P, Boran L, Hicks P, et al · · 2020 · cited 50× · PMID 33089901 · DOI 10.1002/14651858.cd010686.pub2

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Other St. Justine's Hospital trials

Trials by the same sponsor.

NCT04627766 — Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch · NA · recruiting
NCT06537622 — Best Practices Fo Early Diagnosis of Cerebral Palsy · NA · not yet recruiting
NCT06192368 — Virtual Reality Program to Reduce Stress in Neonatal Nurses · NA · completed
NCT06217510 — Pilot Project on the Automatic Design and 3D Printing of Adolescent Idiopathic Scoliosis Braces (Phase 1) · NA · unknown
NCT06173102 — Cranial Orthosis Therapy for Plagiocephaly: an RCT Pilot Study Comparing Cranial Orthosis to the Natural Course · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02977923 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Justine's Hospital
Last refreshed: 21 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02977923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing